{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:26:31Z","timestamp":1789579591186,"version":"build-2803163510"},"reference-count":134,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical Research Council","award":["MR\/S00081X\/1"],"award-info":[{"award-number":["MR\/S00081X\/1"]}]},{"name":"Medical Research Council","award":["RG86932"],"award-info":[{"award-number":["RG86932"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Human cytomegalovirus (HCMV) is a ubiquitous human herpesvirus. In healthy people, primary infection is generally asymptomatic, and the virus can go on to establish lifelong latency in cells of the myeloid lineage. However, HCMV often causes severe disease in the immunosuppressed: transplant recipients and people living with AIDS, and also in the immunonaive foetus. At present, there are several antiviral drugs licensed to control HCMV disease. However, these are all faced with problems of poor bioavailability, toxicity and rapidly emerging viral resistance. Furthermore, none of them are capable of fully clearing the virus from the host, as they do not target latent infection. Consequently, reactivation from latency is a significant source of disease, and there remains an unmet need for treatments that also target latent infection. This review briefly summarises the most common HCMV antivirals used in clinic at present and discusses current research into targeting the latent HCMV reservoir.<\/jats:p>","DOI":"10.3390\/v13050817","type":"journal-article","created":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T21:35:39Z","timestamp":1619904939000},"page":"817","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["HCMV Antivirals and Strategies to Target the Latent Reservoir"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9175-0568","authenticated-orcid":false,"given":"Marianne R.","family":"Perera","sequence":"first","affiliation":[{"name":"Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Addenbrooke\u2019s Hospital, Hills Road, Cambridge CB2 0QQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Wills","sequence":"additional","affiliation":[{"name":"Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Addenbrooke\u2019s Hospital, Hills Road, Cambridge CB2 0QQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Sinclair","sequence":"additional","affiliation":[{"name":"Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Addenbrooke\u2019s Hospital, Hills Road, Cambridge CB2 0QQ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/rmv.655","article-title":"Review of Cytomegalovirus Seroprevalence and Demographic Characteristics Associated with Infection","volume":"20","author":"Cannon","year":"2010","journal-title":"Rev. Med. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Wang, Y.-Q., and Zhao, X.-Y. (2020). Human Cytomegalovirus Primary Infection and Reactivation: Insights from Virion-Carried Molecules. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.01511"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Dell\u2019Oste, V., Biolatti, M., Galitska, G., Griffante, G., Gugliesi, F., Pasquero, S., Zingoni, A., Cerboni, C., and De Andrea, M. (2020). Tuning the Orchestra: HCMV vs. Innate Immunity. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.00661"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.4049\/jimmunol.1800171","article-title":"Cytomegalovirus: Shape-Shifting the Immune System","volume":"200","author":"Picarda","year":"2018","journal-title":"J. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.virusres.2010.10.031","article-title":"Human Cytomegalovirus Immunity and Immune Evasion","volume":"157","author":"Jackson","year":"2011","journal-title":"Virus Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1073\/pnas.95.7.3937","article-title":"Cytomegalovirus Remains Latent in a Common Precursor of Dendritic and Myeloid Cells","volume":"95","author":"Hahn","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1099\/0022-1317-77-12-3099","article-title":"Detection of Endogenous Human Cytomegalovirus in CD34+ Bone Marrow Progenitors","volume":"77","author":"Mendelson","year":"1996","journal-title":"J. Gen. Virol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1099\/0022-1317-72-9-2059","article-title":"Monocytes Are a Major Site of Persistence of Human Cytomegalovirus in Peripheral Blood Mononuclear Cells","volume":"72","author":"Sissons","year":"1991","journal-title":"J. Gen. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/path.4437","article-title":"The Pathogenesis of Human Cytomegalovirus","volume":"235","author":"Griffiths","year":"2015","journal-title":"J. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/S0163-4453(17)30197-4","article-title":"Congenital Cytomegalovirus\u2014Who, When, What-with and Why to Treat?","volume":"74","author":"Lim","year":"2017","journal-title":"J. Infect."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jcv.2007.09.004","article-title":"Congenital Cytomegalovirus (CMV) Infection as a Cause of Permanent Bilateral Hearing Loss: A Quantitative Assessment","volume":"41","author":"Grosse","year":"2008","journal-title":"J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/rmv.544","article-title":"New Estimates of the Prevalence of Neurological and Sensory Sequelae and Mortality Associated with Congenital Cytomegalovirus Infection","volume":"17","author":"Dollard","year":"2007","journal-title":"Rev. Med. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1093\/cid\/ciq085","article-title":"Attribution of Congenital Cytomegalovirus Infection to Primary versus Non-Primary Maternal Infection","volume":"52","author":"Wang","year":"2011","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/rmv.1744","article-title":"The Apparent Paradox of Maternal Seropositivity as a Risk Factor for Congenital Cytomegalovirus Infection: A Population-Based Prediction Model","volume":"23","author":"Dekker","year":"2013","journal-title":"Rev. Med. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/cid\/cix337","article-title":"Risk Factors for Congenital Cytomegalovirus Infection Following Primary and Nonprimary Maternal Infection: A Prospective Neonatal Screening Study Using Polymerase Chain Reaction in Saliva","volume":"65","author":"Magny","year":"2017","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJM198010233031702","article-title":"Molecular Epidemiology of Cytomegalovirus Infections in Women and Their Infants","volume":"303","author":"Huang","year":"1980","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1056\/NEJM200105033441804","article-title":"Intrauterine Transmission of Cytomegalovirus to Infants of Women with Preconceptional Immunity","volume":"344","author":"Boppana","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1086\/600882","article-title":"Birth Prevalence and Natural History of Congenital Cytomegalovirus (CMV) Infection in a Highly Seroimmune Population","volume":"49","author":"Yamamoto","year":"2009","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Shenk, T.E., and Stinski, M.F. (2008). Cytomegalovirus Cell Tropism. Human Cytomegalovirus, Springer. Current Topics in Microbiology and Immunology.","DOI":"10.1007\/978-3-540-77349-8"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Arvin, A., Campadelli-Fiume, G., Mocarski, E., Moore, P.S., Roizman, B., Whitley, R., and Yamanishi, K. (2007). Virus entry into host, establishment of infection, spread in host, mechanisms of tissue damage. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis, Cambridge University Press.","DOI":"10.1017\/CBO9780511545313"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1111\/j.1600-6143.2012.04087.x","article-title":"Cytomegalovirus Replication Kinetics in Solid Organ Transplant Recipients Managed by Preemptive Therapy","volume":"12","author":"Atabani","year":"2012","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrneph.2010.141","article-title":"Management of Cytomegalovirus Infection in Solid Organ Transplantation","volume":"6","author":"Kotton","year":"2010","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(88)90685-X","article-title":"Symptomatic Cytomegalovirus Infection in Seropositive Kidney Recipients: Reinfection with Donor Virus Rather than Reactivation of Recipient Virus","volume":"2","author":"Grundy","year":"1988","journal-title":"Lancet Lond. Engl."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1399-3062.2010.00504.x","article-title":"Pre-Transplant Cytomegalovirus (CMV) Serostatus Remains the Most Important Determinant of CMV Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation in the Era of Surveillance and Preemptive Therapy","volume":"12","author":"George","year":"2010","journal-title":"Transpl. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/bmb\/ldz031","article-title":"Advances in the Treatment of Cytomegalovirus","volume":"131","author":"Krishna","year":"2019","journal-title":"Br. Med. Bull."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/cmi.2014.75","article-title":"The Immunology of Human Cytomegalovirus Latency: Could Latent Infection Be Cleared by Novel Immunotherapeutic Strategies?","volume":"12","author":"Wills","year":"2015","journal-title":"Cell. Mol. Immunol."},{"key":"ref_27","first-page":"123","article-title":"CMV Escapes!","volume":"34","author":"Froberg","year":"2004","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1593\/neo.81178","article-title":"The Story of Human Cytomegalovirus and Cancer: Increasing Evidence and Open Questions","volume":"11","author":"Michaelis","year":"2009","journal-title":"Neoplasia"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Shenk, T.E., and Stinski, M.F. (2008). Cytomegalovirus Vaccine Development. Human Cytomegalovirus, Springer. Current Topics in Microbiology and Immunology.","DOI":"10.1007\/978-3-540-77349-8"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1021\/jm00359a023","article-title":"9-(1,3-Dihydroxy-2-Propoxymethyl)Guanine: A New Potent and Selective Antiherpes Agent","volume":"26","author":"Martin","year":"1983","journal-title":"J. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/358160a0","article-title":"Human Cytomegalovirus UL97 Open Reading Frame Encodes a Protein That Phosphorylates the Antiviral Nucleoside Analogue Ganciclovir","volume":"358","author":"Littler","year":"1992","journal-title":"Nature"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1128\/AAC.43.8.1941","article-title":"Acyclovir Is Phosphorylated by the Human Cytomegalovirus UL97 Protein","volume":"43","author":"Talarico","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/sj.gt.3300913","article-title":"Ganciclovir-Mediated in Vivo Elimination of Myeloid Leukemic Cells Expressing the HSVtk Gene Induces HSVtk Loss Variants","volume":"6","author":"Braakman","year":"1999","journal-title":"Gene Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/AAC.28.2.240","article-title":"Activity of 9-(1,3-Dihydroxy-2-Propoxymethyl)Guanine Compared with That of Acyclovir against Human, Monkey, and Rodent Cytomegaloviruses","volume":"28","author":"Freitas","year":"1985","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1128\/jvi.53.3.776-780.1985","article-title":"Inhibition of Cellular DNA Polymerase Alpha and Human Cytomegalovirus-Induced DNA Polymerase by the Triphosphates of 9-(2-Hydroxyethoxymethyl)Guanine and 9-(1,3-Dihydroxy-2-Propoxymethyl)Guanine","volume":"53","author":"Mar","year":"1985","journal-title":"J. Virol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"17462","DOI":"10.1073\/pnas.1405981111","article-title":"Mechanism of Ganciclovir-Induced Chain Termination Revealed by Resistant Viral Polymerase Mutants with Reduced Exonuclease Activity","volume":"111","author":"Chen","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1073\/pnas.82.8.2473","article-title":"Metabolic Activation of the Nucleoside Analog 9-[(2-Hydroxy-1-(Hydroxymethyl)Ethoxy]Methyl)Guanine in Human Diploid Fibroblasts Infected with Human Cytomegalovirus","volume":"82","author":"Biron","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1128\/AAC.48.7.2782-2783.2004","article-title":"Pharmacokinetics of Oral Valganciclovir and Intravenous Ganciclovir Administered to Prevent Cytomegalovirus Disease in an Adult Patient Receiving Small-Intestine Transplantation","volume":"48","author":"Moreno","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1128\/AAC.44.10.2811-2815.2000","article-title":"Valganciclovir Results in Improved Oral Absorption of Ganciclovir in Liver Transplant Recipients","volume":"44","author":"Pescovitz","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/157489107779561634","article-title":"Novel Therapies for Cytomegalovirus Disease","volume":"2","author":"Steininger","year":"2007","journal-title":"Recent Patents Anti Infect. Drug Discov."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1086\/342385","article-title":"Ganciclovir-Resistant Cytomegalovirus in Organ Transplant Recipients","volume":"35","author":"Limaye","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/ajt.13044","article-title":"Universal Prophylaxis or Preemptive Strategy for Cytomegalovirus Disease After Liver Transplantation: A Systematic Review and Meta-Analysis","volume":"15","author":"Mumtaz","year":"2015","journal-title":"Am. J. Transplant."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1600-6143.2010.03074.x","article-title":"The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients","volume":"10","author":"Humar","year":"2010","journal-title":"Am. J. Transplant."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bbmt.2007.03.009","article-title":"Ganciclovir Inhibits Lymphocyte Proliferation by Impairing DNA Synthesis","volume":"13","author":"Battiwalla","year":"2007","journal-title":"Biol. Blood Marrow Transplant. J. Am. Soc. Blood Marrow Transplant."},{"key":"ref_45","first-page":"160","article-title":"Risk Factors of Ganciclovir-Related Neutropenia after Allogeneic Stem Cell Transplantation: A Retrospective Monocentre Study on 547 Patients","volume":"20","author":"Venton","year":"2014","journal-title":"Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/0002-9343(92)90329-A","article-title":"Mechanism of Action of Foscarnet against Viral Polymerases","volume":"92","author":"Crumpacker","year":"1992","journal-title":"Am. J. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0167-4781(82)90018-5","article-title":"Pyrophosphate Analogues as Inhibitors of DNA Polymerases of Cytomegalovirus, Herpes Simplex Virus and Cellular Origin","volume":"696","author":"Eriksson","year":"1982","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2165\/00003495-199448020-00007","article-title":"Foscarnet. A Reappraisal of Its Antiviral Activity, Pharmacokinetic Properties and Therapeutic Use in Immunocompromised Patients with Viral Infections","volume":"48","author":"Wagstaff","year":"1994","journal-title":"Drugs"},{"key":"ref_49","first-page":"41","article-title":"Foscarnet Sodium","volume":"25","author":"Minor","year":"1991","journal-title":"DICP Ann. Pharmacother."},{"key":"ref_50","first-page":"1502","article-title":"Identification of Enzymes Catalyzing Two-Step Phosphorylation of Cidofovir and the Effect of Cytomegalovirus Infection on Their Activities in Host Cells","volume":"50","author":"Cihlar","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1128\/AAC.41.3.594","article-title":"Effect of Incorporation of Cidofovir into DNA by Human Cytomegalovirus DNA Polymerase on DNA Elongation","volume":"41","author":"Xiong","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/rmv.1873","article-title":"Human Cytomegalovirus Antiviral Drug Resistance in Hematopoietic Stem Cell Transplantation: Current State of the Art","volume":"26","author":"Campos","year":"2016","journal-title":"Rev. Med. Virol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1093\/infdis\/jiz493","article-title":"Advances in the Development of Therapeutics for Cytomegalovirus Infections","volume":"221","author":"Acosta","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/FTD.0000000000000353","article-title":"Brincidofovir Is Not a Substrate for the Human Organic Anion Transporter 1: A Mechanistic Explanation for the Lack of Nephrotoxicity Observed in Clinical Studies","volume":"38","author":"Tippin","year":"2016","journal-title":"Ther. Drug Monit."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1182\/blood-2016-06-688432","article-title":"How I Treat Resistant Cytomegalovirus Infection in Hematopoietic Cell Transplantation Recipients","volume":"128","author":"Shah","year":"2016","journal-title":"Blood"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"10884","DOI":"10.1128\/JVI.05265-11","article-title":"The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase","volume":"85","author":"Goldner","year":"2011","journal-title":"J. Virol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Shigle, T.L., Handy, V.W., and Chemaly, R.F. (2020). Letermovir and Its Role in the Prevention of Cytomegalovirus Infection in Seropositive Patients Receiving an Allogeneic Hematopoietic Cell Transplant. Ther. Adv. Hematol., 11.","DOI":"10.1177\/2040620720937150"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40265-017-0860-8","article-title":"Letermovir: First Global Approval","volume":"78","author":"Kim","year":"2018","journal-title":"Drugs"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMoa1714656","article-title":"Maribavir for Preemptive Treatment of Cytomegalovirus Reactivation","volume":"381","author":"Maertens","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jcv.2006.07.010","article-title":"Maribavir Sensitivity of Cytomegalovirus Isolates Resistant to Ganciclovir, Cidofovir or Foscarnet","volume":"37","author":"Drew","year":"2006","journal-title":"J. Clin. Virol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1128\/AAC.00577-06","article-title":"Maribavir Antagonizes the Antiviral Action of Ganciclovir on Human Cytomegalovirus","volume":"50","author":"Chou","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1086\/421999","article-title":"National Vaccine Advisory Committee Vaccine Development to Prevent Cytomegalovirus Disease: Report from the National Vaccine Advisory Committee","volume":"39","author":"Arvin","year":"2004","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1099\/vir.0.83523-0","article-title":"Human Cytomegalovirus Serum Neutralizing Antibodies Block Virus Infection of Endothelial\/Epithelial Cells, but Not Fibroblasts, Early during Primary Infection","volume":"89","author":"Gerna","year":"2008","journal-title":"J. Gen. Virol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1128\/AAC.04295-14","article-title":"A High-Affinity Native Human Antibody Neutralizes Human Cytomegalovirus Infection of Diverse Cell Types","volume":"59","author":"Kauvar","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1399-0012.2007.00750.x","article-title":"CMV-Hyperimmune Globulin for Preventing Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients: A Meta-Analysis","volume":"22","author":"Bonaros","year":"2008","journal-title":"Clin. Transplant."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Ishida, J.H., Patel, A., Mehta, A.K., Gatault, P., McBride, J.M., Burgess, T., Derby, M.A., Snydman, D.R., Emu, B., and Feierbach, B. (2017). Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients. Antimicrob. Agents Chemother., 61.","DOI":"10.1128\/AAC.01794-16"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1099\/vir.0.80285-0","article-title":"Vascular Endothelial and Smooth Muscle Cells Are Unlikely to Be Major Sites of Latency of Human Cytomegalovirus in Vivo","volume":"85","author":"Reeves","year":"2004","journal-title":"J. Gen. Virol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1161\/01.RES.0000255691.76142.4a","article-title":"Phenotypic Heterogeneity of the Endothelium: I. Structure, Function, and Mechanisms","volume":"100","author":"Aird","year":"2007","journal-title":"Circ. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.isci.2018.05.003","article-title":"Human Organ-Specific Endothelial Cell Heterogeneity","volume":"4","author":"Marcu","year":"2018","journal-title":"iScience"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1128\/JVI.72.1.95-103.1998","article-title":"Cellular Localization of Latent Murine Cytomegalovirus","volume":"72","author":"Koffron","year":"1998","journal-title":"J. Virol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"8869","DOI":"10.1128\/JVI.00870-09","article-title":"Liver Sinusoidal Endothelial Cells Are a Site of Murine Cytomegalovirus Latency and Reactivation","volume":"83","author":"Seckert","year":"2009","journal-title":"J. Virol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"E10586","DOI":"10.1073\/pnas.1710522114","article-title":"Transcriptome-Wide Characterization of Human Cytomegalovirus in Natural Infection and Experimental Latency","volume":"114","author":"Cheng","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"16255","DOI":"10.1073\/pnas.252630899","article-title":"Human Cytomegalovirus Gene Expression during Infection of Primary Hematopoietic Progenitor Cells: A Model for Latency","volume":"99","author":"Goodrum","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_75","first-page":"63","article-title":"Cytomegalovirus Latency and Latency-Specific Transcription in Hematopoietic Progenitors","volume":"99","author":"Kondo","year":"1995","journal-title":"Scand. J. Infect. Dis. Suppl."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1099\/vir.0.015602-0","article-title":"Analysis of Latent Viral Gene Expression in Natural and Experimental Latency Models of Human Cytomegalovirus and Its Correlation with Histone Modifications at a Latent Promoter","volume":"91","author":"Reeves","year":"2010","journal-title":"J. Gen. Virol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e00013-18","DOI":"10.1128\/mBio.00013-18","article-title":"Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing","volume":"9","author":"Shnayder","year":"2018","journal-title":"mBio"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00430-019-00581-1","article-title":"HCMV Latency: What Regulates the Regulators?","volume":"208","author":"Elder","year":"2019","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Dooley, A.L., and O\u2019Connor, C.M. (2020). Regulation of the MIE Locus During HCMV Latency and Reactivation. Pathogens, 9.","DOI":"10.3390\/pathogens9110869"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1042\/BST20191110","article-title":"Cell Signaling and Cytomegalovirus Reactivation: What Do Src Family Kinases Have to Do with It?","volume":"48","author":"Reeves","year":"2020","journal-title":"Biochem. Soc. Trans."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"167ra5","DOI":"10.1126\/scitranslmed.3005145","article-title":"Targeting the JMJD2 Histone Demethylases to Epigenetically Control Herpesvirus Infection and Reactivation from Latency","volume":"5","author":"Liang","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13148-019-0654-9","article-title":"Control of Viral Infections by Epigenetic-Targeted Therapy","volume":"11","author":"Nehme","year":"2019","journal-title":"Clin. Epigenetics"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Da\u011f, F., D\u00f6lken, L., Holzki, J., Drabig, A., Weing\u00e4rtner, A., Schwerk, J., Lienenklaus, S., Conte, I., Geffers, R., and Davenport, C. (2014). Reversible Silencing of Cytomegalovirus Genomes by Type I Interferon Governs Virus Latency. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1003962"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1084\/jem.188.3.577","article-title":"Interferon Gamma Regulates Acute and Latent Murine Cytomegalovirus Infection and Chronic Disease of the Great Vessels","volume":"188","author":"Presti","year":"1998","journal-title":"J. Exp. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"12901","DOI":"10.1074\/jbc.RA119.009667","article-title":"Src Family Kinase Activity Drives Cytomegalovirus Reactivation by Recruiting MOZ Histone Acetyltransferase Activity to the Viral Promoter","volume":"294","author":"Dupont","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Kew, V.G., Yuan, J., Meier, J., and Reeves, M.B. (2014). Mitogen and Stress Activated Kinases Act Co-Operatively with CREB during the Induction of Human Cytomegalovirus Immediate-Early Gene Expression from Latency. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004195"},{"key":"ref_87","first-page":"jcs254268","article-title":"CMV-Encoded GPCR PUL33 Activates CREB and Facilitates Its Recruitment to the MIE Locus for Efficient Viral Reactivation","volume":"134","author":"Krishna","year":"2021","journal-title":"J. Cell Sci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3389\/fcimb.2020.00134","article-title":"Measuring the Success of HIV-1 Cure Strategies","volume":"10","author":"Thomas","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.antiviral.2019.03.008","article-title":"HIV \u201cShock and Kill\u201d Therapy: In Need of Revision","volume":"166","author":"Abner","year":"2019","journal-title":"Antivir. Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1099\/vir.0.81161-0","article-title":"An in Vitro Model for the Regulation of Human Cytomegalovirus Latency and Reactivation in Dendritic Cells by Chromatin Remodelling","volume":"86","author":"Reeves","year":"2005","journal-title":"J. Gen. Virol."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Rossetto, C.C., Tarrant-Elorza, M., and Pari, G.S. (2013). Cis and Trans Acting Factors Involved in Human Cytomegalovirus Experimental and Natural Latent Infection of CD14 (+) Monocytes and CD34 (+) Cells. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003366"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.bbagrm.2009.08.001","article-title":"Chromatin Structure Regulates Human Cytomegalovirus Gene Expression during Latency, Reactivation and Lytic Infection","volume":"1799","author":"Sinclair","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1073\/pnas.0408994102","article-title":"Latency, Chromatin Remodeling, and Reactivation of Human Cytomegalovirus in the Dendritic Cells of Healthy Carriers","volume":"102","author":"Reeves","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1128\/JVI.02507-15","article-title":"Human Cytomegalovirus US28 Is Important for Latent Infection of Hematopoietic Progenitor Cells","volume":"90","author":"Humby","year":"2016","journal-title":"J. Virol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"9483","DOI":"10.1128\/JVI.01547-16","article-title":"Long and Short Isoforms of the Human Cytomegalovirus UL138 Protein Silence IE Transcription and Promote Latency","volume":"90","author":"Lee","year":"2016","journal-title":"J. Virol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e06068","DOI":"10.7554\/eLife.06068","article-title":"Release of Human Cytomegalovirus from Latency by a KAP1\/TRIM28 Phosphorylation Switch","volume":"4","author":"Rauwel","year":"2015","journal-title":"eLife"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Collins-McMillen, D., Buehler, J., Peppenelli, M., and Goodrum, F. (2018). Molecular Determinants and the Regulation of Human Cytomegalovirus Latency and Reactivation. Viruses, 10.","DOI":"10.3390\/v10080444"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3390\/v5061395","article-title":"Regulation of Human Cytomegalovirus Transcription in Latency: Beyond the Major Immediate-Early Promoter","volume":"5","author":"Reeves","year":"2013","journal-title":"Viruses"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"srep24674","DOI":"10.1038\/srep24674","article-title":"Transient Activation of Human Cytomegalovirus Lytic Gene Expression during Latency Allows Cytotoxic T Cell Killing of Latently Infected Cells","volume":"6","author":"Krishna","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.20050882","article-title":"Broadly Targeted Human Cytomegalovirus-Specific CD4+ and CD8+ T Cells Dominate the Memory Compartments of Exposed Subjects","volume":"202","author":"Sylwester","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1086\/339963","article-title":"Comparative Analysis of CD8+ T Cell Responses against Human Cytomegalovirus Proteins Pp65 and Immediate Early 1 Shows Similarities in Precursor Frequency, Oligoclonality, and Phenotype","volume":"185","author":"Khan","year":"2002","journal-title":"J. Infect. Dis."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e2023025118","DOI":"10.1073\/pnas.2023025118","article-title":"Bromodomain Proteins Regulate Human Cytomegalovirus Latency and Reactivation Allowing Epigenetic Therapeutic Intervention","volume":"118","author":"Groves","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fcimb.2020.00329","article-title":"Bromodomain Inhibitors as Therapeutics for Herpesvirus-Related Disease: All BETs Are Off?","volume":"10","author":"Groves","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.molcel.2014.05.016","article-title":"The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition","volume":"54","author":"Shi","year":"2014","journal-title":"Mol. Cell"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"36609","DOI":"10.1074\/jbc.M112.410746","article-title":"Bromodomain and Extra-Terminal (BET) Bromodomain Inhibition Activate Transcription via Transient Release of Positive Transcription Elongation Factor b (P-TEFb) from 7SK Small Nuclear Ribonucleoprotein *","volume":"287","author":"Bartholomeeusen","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.chom.2017.03.007","article-title":"Transcriptional Elongation of HSV Immediate Early Genes by the Super Elongation Complex Drives Lytic Infection and Reactivation from Latency","volume":"21","author":"Turner","year":"2017","journal-title":"Cell Host Microbe"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000150510","article-title":"Human Cytomegalovirus Glycoproteins","volume":"39","author":"Britt","year":"1996","journal-title":"Intervirology"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1128\/jvi.70.11.7569-7579.1996","article-title":"The Human Cytotoxic T-Lymphocyte (CTL) Response to Cytomegalovirus Is Dominated by Structural Protein Pp65: Frequency, Specificity, and T-Cell Receptor Usage of Pp65-Specific CTL","volume":"70","author":"Wills","year":"1996","journal-title":"J. Virol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e01560-18","DOI":"10.1128\/mBio.01560-18","article-title":"Tumor Necrosis Factor Alpha Induces Reactivation of Human Cytomegalovirus Independently of Myeloid Cell Differentiation Following Posttranscriptional Establishment of Latency","volume":"9","author":"Forte","year":"2018","journal-title":"mBio"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"11409","DOI":"10.1128\/JVI.05028-11","article-title":"The Latency-Associated UL138 Gene Product of Human Cytomegalovirus Sensitizes Cells to Tumor Necrosis Factor Alpha (TNF-Alpha) Signaling by Upregulating TNF-Alpha Receptor 1 Cell Surface Expression","volume":"85","author":"Montag","year":"2011","journal-title":"J. Virol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1083-8791(03)00087-9","article-title":"Role of Tumor Necrosis Factor-Alpha in Graft-versus-Host Disease and Graft-versus-Leukemia Responses","volume":"9","author":"Korngold","year":"2003","journal-title":"Biol. Blood Marrow Transplant. J. Am. Soc. Blood Marrow Transplant."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13287-020-01615-9","article-title":"Tumor Necrosis Factor \u03b1 in AGVHD Patients Contributed to the Impairment of Recipient Bone Marrow MSC Stemness and Deficiency of Their Hematopoiesis-Promotion Capacity","volume":"11","author":"Ding","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e01754-17","DOI":"10.1128\/mBio.01754-17","article-title":"Latency-Associated Expression of Human Cytomegalovirus US28 Attenuates Cell Signaling Pathways To Maintain Latent Infection","volume":"8","author":"Krishna","year":"2017","journal-title":"mBio"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Buehler, J., Zeltzer, S., Reitsma, J., Petrucelli, A., Umashankar, M., Rak, M., Zagallo, P., Schroeder, J., Terhune, S., and Goodrum, F. (2016). Opposing Regulation of the EGF Receptor: A Molecular Switch Controlling Cytomegalovirus Latency and Replication. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005655"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Buehler, J., Carpenter, E., Zeltzer, S., Igarashi, S., Rak, M., Mikell, I., Nelson, J.A., and Goodrum, F. (2019). Host Signaling and EGR1 Transcriptional Control of Human Cytomegalovirus Replication and Latency. PLoS Pathog., 15.","DOI":"10.1101\/648543"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Mlera, L., Moy, M., Maness, K., Tran, L.N., and Goodrum, F.D. (2020). The Role of the Human Cytomegalovirus UL133-UL138 Gene Locus in Latency and Reactivation. Viruses, 12.","DOI":"10.3390\/v12070714"},{"key":"ref_117","first-page":"1798","article-title":"Multidrug Resistance Proteins MRP3, MRP1, and MRP2 in Lung Cancer: Correlation of Protein Levels with Drug Response and Messenger RNA Levels","volume":"7","author":"Young","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1126\/science.1235047","article-title":"Latency-Associated Degradation of the MRP1 Drug Transporter during Latent Human Cytomegalovirus Infection","volume":"340","author":"Weekes","year":"2013","journal-title":"Science"},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Poole, E., Wills, M., and Sinclair, J. (2017, July 24). Human Cytomegalovirus Latency: Targeting Differences in the Latently Infected Cell with a View to Clearing Latent Infection. Available online: https:\/\/www.hindawi.com\/journals\/njos\/2014\/313761\/.","DOI":"10.1155\/2014\/313761"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"14321","DOI":"10.1038\/ncomms14321","article-title":"Targeting the Latent Cytomegalovirus Reservoir with an Antiviral Fusion Toxin Protein","volume":"8","author":"Krishna","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Krishna, B.A., Miller, W.E., and O\u2019Connor, C.M. (2018). US28: HCMV\u2019s Swiss Army Knife. Viruses, 10.","DOI":"10.3390\/v10080445"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.isci.2019.01.007","article-title":"Monocytes Latently Infected with Human Cytomegalovirus Evade Neutrophil Killing","volume":"12","author":"Elder","year":"2019","journal-title":"iScience"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"8427","DOI":"10.1073\/pnas.1509392112","article-title":"Rationally Designed Chemokine-Based Toxin Targeting the Viral G Protein-Coupled Receptor US28 Potently Inhibits Cytomegalovirus Infection in Vivo","volume":"112","author":"Spiess","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1074\/jbc.M210033200","article-title":"Identification of the First Nonpeptidergic Inverse Agonist for a Constitutively Active Viral-Encoded G Protein-Coupled Receptor","volume":"278","author":"Casarosa","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Groof, T.W.M.D., Elder, E.G., Heukers, R., Lim, E.Y., Wills, M., Sinclair, J.H., and Smit, M.J. (2020). Targeting the Latent Human Cytomegalovirus Reservoir with Virus Specific Nanobodies. bioRxiv.","DOI":"10.1101\/2020.05.12.071860"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"102994","DOI":"10.1016\/j.ebiom.2020.102994","article-title":"Ex-Vivo Delivery of Monoclonal Antibody (Rituximab) to Treat Human Donor Lungs Prior to Transplantation","volume":"60","author":"Ku","year":"2020","journal-title":"EBioMedicine"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41467-018-08261-z","article-title":"Inactivating Hepatitis C Virus in Donor Lungs Using Light Therapies during Normothermic Ex Vivo Lung Perfusion","volume":"10","author":"Galasso","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e13514","DOI":"10.1111\/tid.13514","article-title":"Macrophage Depletion of CMV Latently Infected Donor Hearts Ameliorates Recipient Accelerated Chronic Rejection","volume":"23","author":"Haese","year":"2020","journal-title":"Transpl. Infect. Dis."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/j.healun.2020.01.1310","article-title":"Targeting Latent Human Cytomegalovirus (CMV) with a Novel Fusion Toxin Protein during Ex Vivo Lung Perfusion","volume":"39","author":"Ribeiro","year":"2020","journal-title":"J. Heart Lung Transplant."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s13665-013-0058-9","article-title":"Ex Vivo Lung Perfusion (EVLP)","volume":"2","author":"Cypel","year":"2013","journal-title":"Curr. Respir. Care Rep."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1053\/j.optechstcvs.2015.03.001","article-title":"Ex Vivo Lung Perfusion","volume":"19","author":"Cypel","year":"2014","journal-title":"Oper. Tech. Thorac. Cardiovasc. Surg."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"4ra9","DOI":"10.1126\/scitranslmed.3000266","article-title":"Functional Repair of Human Donor Lungs by IL-10 Gene Therapy","volume":"1","author":"Cypel","year":"2009","journal-title":"Sci. Transl. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1128\/JVI.73.6.4806-4812.1999","article-title":"Quantitative Analysis of Latent Human Cytomegalovirus","volume":"73","author":"Slobedman","year":"1999","journal-title":"J. Virol."},{"key":"ref_134","first-page":"224","article-title":"Treatment of Transplant Kidneys during Machine Perfusion","volume":"34","author":"Hosgood","year":"2021","journal-title":"Transpl. Int. Off. J. Eur. Soc. Organ. Transplant."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/5\/817\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:56:32Z","timestamp":1760162192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/5\/817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,1]]},"references-count":134,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["v13050817"],"URL":"https:\/\/doi.org\/10.3390\/v13050817","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,1]]}}}